title: Nuclear medicine studies using pharmacologic intervention confirm both renovascular hypertension and improvement in cerebral perfusion after surgery in a child with moyamoya disease.
authors.affiliation: Department of Nuclear Medicine, Prince of Wales and Sydney Children's Hospitals, Randwick, Australia. frank.fiumara@health.qld.gov.au
authors.forename: Frank
authors.initials: F
authors.lastname: Fiumara
authors.forename: Carolyn
authors.initials: C
authors.lastname: Louda
authors.forename: Monica A
authors.initials: MA
authors.lastname: Rossleigh
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Rosenberg
authors.forename: Gad
authors.initials: G
authors.lastname: Kainer
mesh_terms: D002536:Cerebral Arteries / Q000000981:diagnostic imaging; D002560:Cerebrovascular Circulation / Q000502:physiology*; D002648:Child; D005260:Female; D006801:Humans; D006978:Hypertension, Renovascular / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D009072:Moyamoya Disease / Q000150:complications* / Q000188:drug therapy* / Q000601:surgery; D009392:Nephrectomy; D009683:Nuclear Medicine; D011877:Radionuclide Imaging; D012077:Renal Artery / Q000000981:diagnostic imaging; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D014057:Tomography, X-Ray Computed
chemical_list: D019783:Technetium Tc 99m Dimercaptosuccinic Acid